NO20065126L - D-homo-17-chloro-16 (17) -en-steroids. - Google Patents

D-homo-17-chloro-16 (17) -en-steroids.

Info

Publication number
NO20065126L
NO20065126L NO20065126A NO20065126A NO20065126L NO 20065126 L NO20065126 L NO 20065126L NO 20065126 A NO20065126 A NO 20065126A NO 20065126 A NO20065126 A NO 20065126A NO 20065126 L NO20065126 L NO 20065126L
Authority
NO
Norway
Prior art keywords
homo
chloro
steroids
preparation
ensteroids
Prior art date
Application number
NO20065126A
Other languages
Norwegian (no)
Inventor
Sven Ring
Guenter Kaufmann
Ralf Wyrwa
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20065126L publication Critical patent/NO20065126L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Oppfinnelsen vedrører D-homo-17-klor-16(17)-en-steroider med formel (I) som har en androgen aktivitet, fremgangsmåte for fremstillingen derav, farmasøytiske preparater som inneholder nevnte forbindelser og anvendelsen derav for fremstilling av medikamenter.The invention relates to D-homo-17-chloro-16 (17) -ensteroids of formula (I) having an androgenic activity, process for the preparation thereof, pharmaceutical compositions containing said compounds and the use thereof for the preparation of medicaments.

NO20065126A 2004-04-08 2006-11-07 D-homo-17-chloro-16 (17) -en-steroids. NO20065126L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004018441A DE102004018441B4 (en) 2004-04-08 2004-04-08 D-homo-17-chloro-16 (17) and steroids
PCT/EP2005/003792 WO2005097819A1 (en) 2004-04-08 2005-04-07 D-homo-17-chloro-16(17)en steroids

Publications (1)

Publication Number Publication Date
NO20065126L true NO20065126L (en) 2007-01-04

Family

ID=34966688

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065126A NO20065126L (en) 2004-04-08 2006-11-07 D-homo-17-chloro-16 (17) -en-steroids.

Country Status (18)

Country Link
EP (1) EP1735331A1 (en)
KR (1) KR20070007910A (en)
CN (1) CN1997659A (en)
AR (1) AR048536A1 (en)
AU (1) AU2005231970A1 (en)
CA (1) CA2563541A1 (en)
CR (1) CR8736A (en)
DE (1) DE102004018441B4 (en)
EA (1) EA200601842A1 (en)
EC (1) ECSP066973A (en)
GT (1) GT200500084A (en)
MX (1) MXPA06012849A (en)
NO (1) NO20065126L (en)
PA (1) PA8629401A1 (en)
SV (1) SV2005002076A (en)
TW (1) TW200603812A (en)
WO (1) WO2005097819A1 (en)
ZA (1) ZA200609275B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4788218A (en) * 1984-05-21 1988-11-29 Sri International 17 a β-hydroxy-7 α-methyl-d-homo-19-norandrost-4,16-diene-3-one and the 17-esters thereof: methods of preparation and uses
DE4042005A1 (en) * 1990-12-22 1992-06-25 Schering Ag D-HOMO- (16-EN) -11 (BETA) -ARYL-4-ESTRENE
EP0640294B2 (en) * 1993-08-21 1999-10-20 Societe Des Produits Nestle S.A. Production of a seasoning
DE10151365A1 (en) * 2001-10-17 2003-04-30 Schering Ag New 17-chloro-D-homosteroids, useful as estrogen receptor ligands for female or male contraception or treating benign or malignant proliferative diseases of the ovary

Also Published As

Publication number Publication date
DE102004018441B4 (en) 2007-12-20
CN1997659A (en) 2007-07-11
CR8736A (en) 2007-08-28
EP1735331A1 (en) 2006-12-27
ECSP066973A (en) 2006-12-29
AR048536A1 (en) 2006-05-03
PA8629401A1 (en) 2006-07-03
GT200500084A (en) 2006-03-24
CA2563541A1 (en) 2005-10-20
EA200601842A1 (en) 2007-04-27
TW200603812A (en) 2006-02-01
DE102004018441A1 (en) 2005-11-03
WO2005097819A1 (en) 2005-10-20
ZA200609275B (en) 2009-08-26
KR20070007910A (en) 2007-01-16
AU2005231970A1 (en) 2005-10-20
SV2005002076A (en) 2005-12-06
MXPA06012849A (en) 2007-01-26

Similar Documents

Publication Publication Date Title
NO20070224L (en) 2-urea-4-phenylthiazole derivatives, preparation and therapeutic use thereof
ATE433447T1 (en) PYRIMIIDINE COMPOUNDS
NO20074592L (en) Acetylenyl-pyrazolo-pyrimidine derivatives as mGluR2 antagonists
NO20050828L (en) indole-3-sulfur derivatives
NO20081729L (en) New diazaspiroalkanes and their use in the treatment of CCR8-mediated diseases
NO20054329L (en) Adamantan derivatives, processes for their preparation, and pharmaceutical compositions which include them
NO20050741L (en) New Process for the Synthesis and New Crystalline Form of Agomelatine and Pharmaceutical Compositions Containing the
NO20056192L (en) Capase inhibitors and their use
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
MX2009004746A (en) 1,2,4-triazole derivatives as sigma receptor inhibitors.
NO20050525L (en) Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
NO20055219L (en) New connections
MX2009000884A (en) Pyridizinone derivatives.
MX2010009752A (en) Oxadiazoanthracene compounds for the treatment of diabetes.
MY148480A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
NO20074258L (en) Pyridine-2-carboxamide derivatives as MGLUR5 antagonists
NO20092723L (en) Indazolyl esters and amide derivatives for the treatment of glucocorticoid receptor-mediated diseases
NO20081844L (en) Therapeutic compounds
TW200738659A (en) Novel compounds
NO20064078L (en) Substituted azetidine compositions, their preparation and use as drugs
NO20084328L (en) New connections
WO2009082152A3 (en) Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient
NO20082496L (en) pyrazine derivatives
ME00680B (en) Novel diomestine derivatives, method for preparing same and pharmaceutical compositions containing same
NO20064344L (en) Caspase Inhibitors and Uses thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application